Healthcare provider profile · identity verified

Hong Yu, M.D.

Geriatric Medicine · HILLSBOROUGH, NC · NPI 1467674465

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	591	45
Atorvastatin Calcium	Atorvastatin Calcium	374	52
Sertraline Hcl	Sertraline Hcl	310	42
Levothyroxine Sodium	Levothyroxine Sodium	293	29
Trazodone Hcl	Trazodone Hcl	258	39
Gabapentin	Gabapentin	252	36
Mirtazapine	Mirtazapine	252	46
Amlodipine Besylate	Amlodipine Besylate	242	39
Furosemide	Furosemide	221	33
Metoprolol Succinate	Metoprolol Succinate	195	29
Lisinopril	Lisinopril	176	22
Omeprazole	Omeprazole	175	27
Potassium Chloride	Potassium Chloride	140	19
Donepezil Hcl	Donepezil Hcl	136	14
Carvedilol	Carvedilol	133	20
Levetiracetam	Levetiracetam	133	16
Warfarin Sodium	Warfarin Sodium	128	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	123	18
Metoprolol Tartrate	Metoprolol Tartrate	113	22
Pantoprazole Sodium	Pantoprazole Sodium	108	21
Losartan Potassium	Losartan Potassium	107	15
Tamsulosin Hcl	Tamsulosin Hcl	105	16
Hydralazine Hcl	Hydralazine Hcl	96	11
Memantine Hcl	Memantine Hcl	88	13
Pravastatin Sodium	Pravastatin Sodium	83	12
Rosuvastatin Calcium	Rosuvastatin Calcium	78	11
Divalproex Sodium	Divalproex Sodium	74	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	73	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	71	30
Latanoprost	Latanoprost	71	15
Spironolactone	Spironolactone	71	13
Risperidone	Risperidone	68	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	67	suppressed
Metformin Hcl	Metformin Hcl	66	12
Torsemide	Torsemide	65	suppressed
Duloxetine Hcl	Duloxetine Hcl	62	11
Famotidine	Famotidine	62	suppressed
Lactulose	Lactulose	57	16
Citalopram Hbr	Citalopram Hydrobromide	56	suppressed
Ciclopirox	Ciclopirox Olamine	54	32
Quetiapine Fumarate	Quetiapine Fumarate	51	12
Finasteride	Finasteride	50	suppressed
Allopurinol	Allopurinol	49	suppressed
Ketoconazole	Ketoconazole	47	27
Meloxicam	Meloxicam	46	suppressed
Buspirone Hcl	Buspirone Hcl	44	11
Myrbetriq	Mirabegron	44	suppressed
Amiodarone Hcl	Amiodarone Hcl	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Jardiance	Empagliflozin	42	suppressed
Xarelto	Rivaroxaban	39	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	suppressed
Novolog Flexpen	Insulin Aspart	37	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	28
Cephalexin	Cephalexin	35	16
Fluticasone Propionate	Fluticasone Propionate	35	11
Baclofen	Baclofen	34	suppressed
Loxapine	Loxapine Succinate	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Nystatin	Nystatin	29	17
Ondansetron Odt	Ondansetron	29	12
Triamcinolone Acetonide	Triamcinolone Acetonide	29	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Gemtesa	Vibegron	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Lamotrigine	Lamotrigine	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	14
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Prednisone	Prednisone	20	suppressed
Nystop	Nystatin	19	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Prednisolone Acetate	Prednisolone Acetate	19	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Lorazepam	Lorazepam	18	11
Valsartan	Valsartan	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Estradiol	Estradiol	16	suppressed
Glipizide	Glipizide	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	15	suppressed
Atropine Sulfate	Atropine Sulfate	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Multaq	Dronedarone Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	11
Promethazine Hcl	Promethazine Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Neupro	Rotigotine	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Silodosin	Silodosin	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Linzess	Linaclotide	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error